Search
Search Results
Found 63 items.
-
Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia
Published: 28 June 2023396PDF: 148 -
Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCoV-19) vaccine: report of two cases
Published: 23 May 20223561PDF: 239 -
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024284PDF: 97 -
Thrombin generation assay in COVID-19 patients shows a hypocoagulable pattern
Published: 22 October 20242PDF: 0Supplementary: 0 -
Artificial intelligence and machine learning in hemostasis and thrombosis
Published: 31 January 20241495PDF: 292 -
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Published: 27 June 20231005PDF: 226Supplementary File: 106 -
Allopurinol-induced acquired von Willebrand syndrome
Published: 25 October 20231448PDF: 136 -
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries
Published: 12 October 2023622PDF: 175 -
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history
Published: 7 November 20221771PDF: 196 -
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review
Published: 24 October 2022424PDF: 153 -
Stroke in women: anticoagulation in a complicated puzzle
Published: 26 August 2024909PDF: 237 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024461PDF: 208 -
Is non-alcoholic fatty liver disease a prothrombotic risk factor?
Published: 19 May 2023462PDF: 153 -
From rare to aware: confronting Lemierre syndrome.
Published: 21 October 202411PDF: 6 -
Distal deep vein thrombosis: is there a way out of this dark forest?
Published: 4 September 2024385PDF: 114 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024257PDF: 137 -
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study
Published: 12 October 2023183PDF: 95 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024390PDF: 167 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024415PDF: 149 -
Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study
Published: 1 December 20221229PDF: 248 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024967PDF: 105 -
Artificial intelligence, platelets and aspirin
Published: 15 March 2024241PDF: 123 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024746PDF: 147 -
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
Published: 22 April 2024242PDF: 52 -
New perspectives for prevention of the post-thrombotic syndrome
Published: 22 March 20221256PDF: 408 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024243PDF: 108 -
Welcome to the 12th ICTHIC!
Published: 16 May 20241235PDF: 154 -
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
Published: 27 January 2023530PDF: 252 -
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice
Published: 23 May 20224531PDF: 226 -
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know
Published: 13 September 20222101PDF: 216 -
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?
Published: 15 April 20221900PDF: 482 -
Role of platelet autophagy in cardiovascular diseases
Published: 26 August 2024604PDF: 156 -
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy
Published: 21 July 20222797PDF: 273 -
Well begun is half done
Published: 14 December 20221484PDF: 134 -
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study
Published: 27 July 20224001PDF: 322Supplementary Files: 95 -
Antithrombotic therapy in idiopathic infertility
Published: 3 October 202498PDF: 72 -
What is the gender of thrombosis? A natural model of precision medicine
Published: 3 August 2023390PDF: 136 -
Welcome to AICE and sincere wishes for peace for the new year 2024
Published: 27 December 20231161PDF: 88 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241224PDF: 202 -
The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist
Published: 21 August 20241120PDF: 301 -
Oral Communications and Posters
Published: 16 May 2024232PDF: 254 -
The clinical usefulness of measuring thrombin generation
Published: 6 March 2023719PDF: 299 -
Thrombotic thrombocytopenic purpura: much done, but still a lot to do
Published: 29 August 2024389PDF: 129 -
Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond
Published: 3 August 2023987PDF: 224 -
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series
Published: 17 October 20222249PDF: 186 -
Polycythemia vera and management of the thrombotic risk: an update
Published: 20 December 20231682PDF: 210 -
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art
Published: 4 September 2024479PDF: 105SUPPLEMENTARY MATERIAL: 73 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024874PDF: 120 -
Gene transfer in hemophilia A: not cogent yet
Published: 20 April 20221960PDF: 203 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024260PDF: 140 -
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
Published: 9 March 2023492PDF: 310 -
The new era of anticoagulation: factor XI and XII inhibitors
Published: 7 June 20231734PDF: 762 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024262PDF: 97 -
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231134PDF: 397 -
An ecological alliance against air pollution and cardiovascular disease
Published: 22 March 20221629PDF: 234 -
Growing weapons to fight hemophilia
Published: 23 February 2023626PDF: 269 -
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry
Published: 23 May 20225061PDF: 408APPENDIX: 93 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024284PDF: 116 -
The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
Published: 26 April 20221818PDF: 301
1 - 63 of 63 items